CRA is proud to announce the addition of Chris Zealey as a vice president in the firm’s Life Sciences Practice.
“I am pleased to welcome Chris to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “His areas of expertise include cross functional and medical strategic and tactical planning, insight generation, scientific communication strategy, and clinical positioning. He joins a team dedicated to addressing CRA’s life sciences clients’ most complex business challenges.”
“Chris has an impressive track record of supporting medical affairs clients using clinical, stakeholder, and market insights to form actionable and measurable strategies,” said Dr. Gregory K. Bell, CRA Group Vice President and Life Sciences Practice Leader. “We look forward to working with Chris during an exciting period of growth and opportunity for our Practice and the broader industry. As clients face increasingly complex medical affairs and launch decisions, Chris’s experience leveraging data, evidence, and stakeholder perspectives to inform strategy will further strengthen the value we bring to life sciences organizations.
As medical affairs continue to play an increasingly strategic role across the life sciences sector, CRA has expanded its capabilities to help clients navigate complex scientific, clinical, and stakeholder engagement challenges. The growing team of senior Life Sciences professionals brings deep experience across medical affairs strategy, enabling the company to deliver integrated solutions to life sciences organizations.
Before joining CRA, Mr. Zealey was a partner at a life sciences and pharmaceutical consulting firm where he led client engagements across the firm’s consulting offerings, including strategic and tactical planning, healthcare professional and patient insight generation, strategic scientific narrative and platform development, and medical intelligence to support product launches and optimize in-line asset strategies.
Mr. Zealey holds a MSc in Biotechnology with a concentration in Business and Policy from McGill University and a BSc in Microbiology from the University of Waterloo.
About CRA’s Life Sciences Practice
CRA’s Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.
